GlassScriptPhysician profile
Valerie E Flynn
NPI 1992996771
$3,002.65
in general payments reported to CMS, 2019-2025
19 companies · $721 in 2025
The $721 reported for 2025 was less than what a typical Dermatology provider received nationally (typical 2025 total: $772).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $497 · 2020: $260 · 2021: $105 · 2022: $396 · 2023: $484 · 2024: $540 · 2025: $721.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,596 · Education: $150.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,595.56 |
| Education | $149.64 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $888.73 | 2019-2025 | |
| Janssen Biotech, INC. | $777.15 | 2019-2025 | Tremfya |
| Regeneron Healthcare Solutions, INC. | $385.80 | 2019-2025 | Dupixent, Libtayo |
| Lilly USA, LLC | $163.81 | 2023-2025 | Taltz, Olumiant, Ebglyss |
| Amgen INC. | $156.81 | 2019-2025 | Otezla, Otezla |
| Sun Pharmaceutical Industries INC. | $147.41 | 2025 | |
| Genzyme Corporation | $90.92 | 2019-2025 | |
| Pfizer INC. | $90.15 | 2019-2022 | |
| Arcutis Biotherapeutics, INC. | $69.82 | 2023-2025 | Zoryve |
| Novartis Pharmaceuticals Corporation | $50.26 | 2019-2022 | |
| Organon LLC | $35.50 | 2024 | |
| Dusa Pharmaceuticals, INC. | $26.29 | 2019 | |
| Dermavant Sciences, INC. | $23.45 | 2024 | Vtama |
| Allergan, INC. | $20.81 | 2022 | |
| E.R. Squibb & Sons, L.L.C. | $19.58 | 2023 | Sotyktu |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ucb, INC. | $15.29 | 2025 | Bimzelx |
| Kyowa Kirin, INC. | $13.89 | 2020 | |
| Incyte Corporation | $13.89 | 2025 | Opzelura |
| Leo Pharma INC. | $13.09 | 2023 | Adbry |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Valerie Flynn listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.